Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL340 Target Snapshot

Cytochrome P450 3A4 · SINGLE PROTEIN · Homo sapiens

35,011Compounds
5,360Assays
127Approved Drugs
14,703.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P08684. Use UniProt P08684 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P08684 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome P450 3A4 as ChEMBL target CHEMBL340, mapped to UniProt P08684. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome P450 3A4
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL340
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P08684
Cytochrome P450 3A4
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome P450 3A4 is the right protein anchor across sources, using UniProt P08684 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome P450 3A4
UniProt AccessionP08684
Component TypeProtein
Sequence Length503 aa

Cytochrome P450 3A4

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome P450 3A4, mapped to UniProt P08684. Sequence length is 503 aa.

Mapped IDP08684
Review nameCytochrome P450 3A4
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

127
Approved
36
Phase III
59
Phase II
29
Phase I
Assay Mix

Activity Type Distribution

IC5013,549.0
KI1,091.0
EC5045.0
KD18.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1819091 10.66 Ki 0.022 Preclinical
CHEMBL1819089 10.59 Ki 0.026 Preclinical
CHEMBL3407558 10.3 IC50 0.0503 Preclinical
CHEMBL3125537 10.02 IC50 0.0962 Preclinical
CHEMBL3407554 9.99 IC50 0.102 Preclinical
CHEMBL1271703 9.52 IC50 0.3 Preclinical
CHEMBL3407575 9.48 IC50 0.33 Preclinical
CHEMBL4593464 9.4 IC50 0.4 Preclinical
CHEMBL520419 9.4 IC50 0.4 Preclinical
CHEMBL474469 9.3 IC50 0.5 Preclinical
Distribution

pChEMBL Value Distribution

1815
5.0
1096
5.5
703
6.0
448
6.5
295
7.0
112
7.5
42
8.0
19
8.5
23
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

LEVOKETOCONAZOLE
CHEMBL295698
Approved 2021
LEFAMULIN
CHEMBL3291398
Approved 2019
CANNABIDIOL
CHEMBL190461
Approved 2018
COBICISTAT
CHEMBL2095208
Approved 2012
NILOTINIB
CHEMBL255863
Approved 2007
POSACONAZOLE
CHEMBL1397
Approved 2005
DULOXETINE
CHEMBL1175
Approved 2004
APREPITANT
CHEMBL1471
Approved 2003
ALOSETRON
CHEMBL1110
Approved 2000
LOPINAVIR
CHEMBL729
Approved 2000
AMPRENAVIR
CHEMBL116
Approved 1999
NELFINAVIR
CHEMBL584
Approved 1997
MIBEFRADIL
CHEMBL45816
Approved 1997
RITONAVIR
CHEMBL163
Approved 1996
SAQUINAVIR
CHEMBL114
Approved 1995
VINORELBINE
CHEMBL553025
Approved 1994
NEFAZODONE
CHEMBL623
Approved 1994
TACROLIMUS ANHYDROUS
CHEMBL269732
Approved 1994
CISAPRIDE
CHEMBL1729
Approved 1993
ITRACONAZOLE
CHEMBL64391
Approved 1992
SERTRALINE
CHEMBL809
Approved 1991
PODOFILOX
CHEMBL61
Approved 1990
OXICONAZOLE
CHEMBL1262
Approved 1988
NICARDIPINE
CHEMBL1484
Approved 1988
CLOBETASOL PROPIONATE
CHEMBL1159650
Approved 1985
TERFENADINE
CHEMBL17157
Approved 1985
SULCONAZOLE
CHEMBL1221
Approved 1985
MIDAZOLAM
CHEMBL655
Approved 1985
CYCLOSPORINE
CHEMBL160
Approved 1983
DILTIAZEM
CHEMBL23
Approved 1982
ECONAZOLE
CHEMBL808
Approved 1982
VERAPAMIL
CHEMBL6966
Approved 1981
KETOCONAZOLE
CHEMBL157101
Approved 1981
TAMOXIFEN
CHEMBL83
Approved 1977
CLOTRIMAZOLE
CHEMBL104
Approved 1975
MICONAZOLE
CHEMBL91
Approved 1974
TESTOSTERONE
CHEMBL386630
Approved 1972
ERYTHROMYCIN
CHEMBL532
Approved 1964
METYRAPONE
CHEMBL934
Approved 1961
ERGOTAMINE
CHEMBL442
Approved 1948
Source · ChEMBL 36 via Core Engine